Explore
Featured
Recent
Articles
Topics
Login
Upload
Featured
Recent
Articles
Topics
Login
Upload
Search Results for 'Investigational'
Investigational published presentations and documents on DocSlides.
Expanded Access Use of for Investigational Drugs in VA: Focus on COVID-19
by summer
Office of Research Protections, Policy, & Educ...
Stephen A. Bean, PharmD
by lois-ondreau
Investigational Drug Service. Department of Pharm...
Introduction to Research Pharmacy
by trish-goza
Investigational Drug Control and . Patient Safety...
IP Accountability in
by calandra-battersby
Outpatient Clinical Trials. Jessica Rinaldi, CCRP...
IP Accountability in
by mitsue-stanley
Outpatient Clinical Trials. Jessica Rinaldi, CCRP...
Best Practices in the Identification and Management of Alzheimer Agitation
by tatiana-dople
Introduction. Effects of AD Agitation. Agitation ...
1 King & Spalding May 22, 2014
by marina-yarberry
1 King & Spalding ...
Loxo Oncology Expanded Access Program (EAP)
by undialto
EAP Request Details - To be completed Requester Co...
HRS 2012 S-ICD Clinical Highlights
by WiseWolf
Disclaimer. The content in this presentation was p...
Ebola Virus Disease and
by lam
Clinical Care. Part III. : . Experimental Treatmen...
FDA’s Access Mechanisms
by roxanne
When They Work – When They Don’t . And Why. St...
System Treatment Chronic Feferberg Israeli Intelligence Development
by jensen
Improving the health and . well-being of sufferers...
Guidance for Clinical Investigators Sponsors and IRBs Investigational New Drug A
by natalia-silvester
S Department of Health and Human Services Food and...
Clinical Cosmetic and Investigational Dermatology Dove press Dove press
by pamella-moone
The aim of this study was to compare the ef64257c...
Guidance for Industry Codevelopment of Two or More New Investigational Drugs for Use in Combination U
by alida-meadow
S Department of Health and Human Services Food and...
Guidance for Industry Expanded Access to Investigational Drugs for Treatment Use Qs As DRAFT GUIDANCE This guidance document is being di stributed for comment purposes only
by pamella-moone
Comments and suggestions regarding this draft doc...
Guidance for Industry CGMP for Phase Investigational Drugs U
by olivia-moreira
S Department of Health and Human Services Food and...
What is
by calandra-battersby
involved. ? What are your r. esponsibilities?. Ma...
The Clinical Trial Protocol: Writing Considerations
by kittie-lecroy
AMWA Northern California Chapter . 04 Oct 2014. 1...
Endovascular Therapy for Acute Ischemic Stroke
by alida-meadow
ML006 Rev01. Adapted from . Goyal. , Hill, . Demc...
Charging for Investigational Drugs Under an IND Questions and AnswersG
by kittie-lecroy
/Att;¬he; [/;ott;om ];/BBo...
IND Determinations
by lindy-dunigan
An IRB . Infoshort. August 2013. IND. An Investig...
Endovascular Therapy for Acute Ischemic Stroke
by karlyn-bohler
ML006 Rev01. Adapted from . Goyal. , Hill, . Demc...
Expedited Protocol Review
by phoebe-click
An IRB . Infoshort. April 2013. Expedited Definit...
Terminologies in Clinical Research
by trish-goza
Adverse Drug Reactions (ADR). All . noxious . and...
Investigator Responsibilities for Research
by debby-jeon
Jan Zolkower, MSHL, CIP, CCRP. January 13, 2012...
IND Determinations
by debby-jeon
An IRB . Infoshort. August 2013. IND. An Investig...
Moving Into Uncharted Territory
by celsa-spraggs
in Unresectable HCC: . Practical Treatment Update...
Contract Research organizations
by calandra-battersby
A Business Overview . Shannon . Staton. . PharmD...
Pamela Harris, M.D. Percy Ivy, M.D
by min-jolicoeur
.. Jeffrey Moscow, M.D.. James A. Zwiebel, M.D.. ...
Preparing for an FDA Inspection
by tawny-fly
. Kathy Gilmartin, MSN, CRN...
MiSLE Investigational Product Training
by lois-ondreau
Shipping, Receipt and Infusion. July 25, 2018. Ag...
Preparing for an FDA Inspection
by min-jolicoeur
. Kathy Gilmartin, MSN, CRN...
Quality Issues for Clinical Trial Materials
by min-jolicoeur
: . The Chemistry, Manufacturing and Controls (CM...
Opportunities & Challenges:
by pasty-toler
Expanding Access to Hepatitis C Treatment . Gregg...
Orientation for New Clinical Research PERSONNEL
by aaron
Module 4. Presented by . NC TraCS Institute. UNC ...
PARP Inhibitors This program will include a discussion of off-label treatment and investigational a
by conchita-marotz
PARP Inhibitors: What Do We know?. PARP Inhibitor...
From Adjuvant to Metastatic in Melanoma This program will include a discussion of off-label treatment and investigational agents not approved by the FDA for use in the US, and data that were presented in abstract form.
by phoebe-click
From Adjuvant to Metastatic in Melanoma This pro...
Title of Talk Speaker name
by kittie-lecroy
disclosure information. Speaker Name: . Disclosur...
UC DAVIS OFFICE OF RESEARCH
by olivia-moreira
Overview of Good Clinical Practices (GCP) . Inves...
Load More...